Delivery Order SPE2DB20D1109-SPE2DB23FP51M

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,701.30 firm fixed price delivery order is for the supply of Testosterone CYP 200 mg/mL, a specialty pharmaceutical product. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and is the sole...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,189.22 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,965,794 units of 2,000 mg/10 ml testosterone cypionate, a critical medication. The award has an ultimate completion date of September 30, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,170.73 firm fixed-price contract is for the supply of 1,000 mg/10 ml testosterone cypionate vials. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,447.54 firm fixed-price contract is for the supply of testosterone cypionate 200 mg/mL, with a period of performance through March 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Testosterone Cypionate 200 mg/mL. The contract, valued at $1,600.84, is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for $1,746.02 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including...
This federal contract award is for the delivery of Testosterone 1% (50 mg/5 g) pharmaceutical products to the Defense Logistics Agency (DLA). The $3,132.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,239.13 firm fixed-price delivery order is for the supply of Testosterone 1% (50 mg/5 g) pharmaceutical products. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., also known as Amerisourcebergen, valued at up to $999,999,999.00...
This federal contract award, valued at $1,074.35, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical products to support military treatment programs and facilities. The contract is a firm fixed price delivery order, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp serves as the prime...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.84 firm fixed-price contract is for the delivery of testosterone cypionate 200 mg/mL medication, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP51M
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a pharmaceutical product, Testosterone CYP 200 mg/mL, to the Defense Logistics Agency (DLA). The $1,434.54 fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 12:11 PM